After Successful Transplant, Patient Returns To His Passion
Jamil Hill received his first kidney transplant in 1993six years after learning he had a rare kidney disorder called Focal Segmental Glomerulosclerosis, a condition that attacks the kidneys ability to properly perform its filtering function.
In 2006, 13 years after transplant, that kidney failed and Hill was put back on the transplant waiting list and began regular dialysis treatments.
Despite the exhaustion of dialysis, Hill stayed active with his passion: work with local at-risk teens through Cincinnatis Community Action Agency. In addition to training teens at his construction firm each summer, he coaches them in football, basketball and baseball at Shroeder Jr High.
Hill balanced dialysis with his community work for six yearsuntil a partnership with UC Health transplant surgeon E. Steve Woodle, MD, and participation in new research protocols, finally got him to transplantation.
"There are 80,000 patients waiting for kidney transplant in the U.S., says Woodle. "About 20,000 of those are basically un-transplantable because they have so much immunity to other peoples kidneys. That immunity usually manifests itself in the form of high antibody levels.
While Hill was on dialysis, more than 30 of his friends and family were tested to donate a kidney, but none matched. Hills antibodies were far too high and were at risk of rejecting most organs.
To enable a kidney transplant, Hills antibodies would have to be reduced via a treatment called desensitization. However, Hills antibody levels were so high that common therapy would likely fail.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.